Subasumstat by Takeda Pharmaceutical for Relapsed Multiple Myeloma: Likelihood of Approval

Subasumstat is under clinical development by Takeda Pharmaceutical and currently in Phase II for Relapsed Multiple Myeloma.

Alcon tried to sink Aurion’s IPO in ‘Valentine’s Day massacre,’ new lawsuits say

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 25, 2025

Opinion | How Worried Should We Be About a Bird Flu Pandemic?

Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is

August 20, 2024

Talkspace, Bicycle Health Expands Access to Virtual Care for Patients with Opioid Use Disorder

What You Should Know: Today, Talkspace, the largest telemedicine-based therapy provider covered by insurance in the nation, and Bicycle Health, the leading telemedicine-based program for opioid use disorder

February 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.